ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Testosterone in Atrevis hydrogel base = almost double test levels!
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 211687" data-attributes="member: 13851"><p>Not that I am aware of.</p><p></p><p>conversion factors: <em>to ng/dL multiple ng/mL by 100</em></p><p><em></em></p><p><em></em></p><p><em>*The strengths of this study include the detailed blood sampling after single applications of a range of testosterone doses (12.5, 25, 50 mg) to better define the pharmacokinetics of the scrotal skin route, the use of <strong>nandrolone to suppress endogenous testosterone to allow an investigation of testosterone pharmacokinetics without interference by endogenous testosterone, and the use of LC-MS measurement of all steroids.</strong> </em></p><p><em></em></p><p><em>The limitations of this study are that it investigated only a <strong>single administration so that long-term steady-state findings could not be studied. </strong></em></p><p><em><strong></strong></em></p><p><em><strong>The use of nandrolone to suppress endogenous testosterone could, in theory, modify skin or other organs which might influence testosterone absorption or metabolism and, while it cannot be excluded, this possibility would not interfere with the interpretation of our findings relevant to the different testosterone doses studied in random sequence under the same conditions.</strong></em></p><p></p><p></p><p></p><p></p><p><strong>MATERIALS AND METHODS </strong></p><p></p><p><em>This was a single-center, three-phase cross-over pharmacokinetic study of three single doses in a random sequence of testosterone cream<strong> [AndroForte 5, 5% w/v (50 mg/mL) testosterone cream</strong>; Lawley Pharmaceuticals, West Leederville, Australia] administered to healthy volunteers.</em></p><p></p><p></p><p></p><p><strong><em>*<u>AndroForte 5</u> (Lawley Pharmaceuticals, Perth, Australia) is a new <u>5% (50 mg/mL) alcohol-free topical testosterone cream (T cream)</u> approved for use in men with confirmed androgen deficiency.</em></strong></p><p></p><p>[ATTACH=full]17678[/ATTACH]</p><p>[ATTACH=full]17679[/ATTACH]</p><p>[ATTACH=full]17680[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 211687, member: 13851"] Not that I am aware of. conversion factors: [I]to ng/dL multiple ng/mL by 100 *The strengths of this study include the detailed blood sampling after single applications of a range of testosterone doses (12.5, 25, 50 mg) to better define the pharmacokinetics of the scrotal skin route, the use of [B]nandrolone to suppress endogenous testosterone to allow an investigation of testosterone pharmacokinetics without interference by endogenous testosterone, and the use of LC-MS measurement of all steroids.[/B] The limitations of this study are that it investigated only a [B]single administration so that long-term steady-state findings could not be studied. The use of nandrolone to suppress endogenous testosterone could, in theory, modify skin or other organs which might influence testosterone absorption or metabolism and, while it cannot be excluded, this possibility would not interfere with the interpretation of our findings relevant to the different testosterone doses studied in random sequence under the same conditions.[/B][/I] [B]MATERIALS AND METHODS [/B] [I]This was a single-center, three-phase cross-over pharmacokinetic study of three single doses in a random sequence of testosterone cream[B] [AndroForte 5, 5% w/v (50 mg/mL) testosterone cream[/B]; Lawley Pharmaceuticals, West Leederville, Australia] administered to healthy volunteers.[/I] [B][I]*[U]AndroForte 5[/U] (Lawley Pharmaceuticals, Perth, Australia) is a new [U]5% (50 mg/mL) alcohol-free topical testosterone cream (T cream)[/U] approved for use in men with confirmed androgen deficiency.[/I][/B] [ATTACH type="full" alt="Screenshot (9122).png"]17678[/ATTACH] [ATTACH type="full" alt="Screenshot (9124).png"]17679[/ATTACH] [ATTACH type="full" alt="Screenshot (9123).png"]17680[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Testosterone in Atrevis hydrogel base = almost double test levels!
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top